These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38703297)

  • 21. Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts.
    Buchegger F; Adamer F; Schaffland AO; Kosinski M; Grannavel C; Dupertuis YM; de Tribolet N; Mach JP; Delaloye AB
    Int J Cancer; 2004 May; 110(1):145-9. PubMed ID: 15054880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
    Chan C; Fonge H; Lam K; Reilly RM
    Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
    Tang Y; Scollard D; Chen P; Wang J; Holloway C; Reilly RM
    Nucl Med Commun; 2005 May; 26(5):427-32. PubMed ID: 15838425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.
    Chattopadhyay N; Cai Z; Kwon YL; Lechtman E; Pignol JP; Reilly RM
    Breast Cancer Res Treat; 2013 Jan; 137(1):81-91. PubMed ID: 23160926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of Tumor Targeting and In Vivo Biodistribution of 
    El-Safoury DM; Ibrahim AB; El-Setouhy DA; Khowessah OM; Motaleb MA; Sakr TM
    J Pharm Sci; 2021 Aug; 110(8):2955-2965. PubMed ID: 33812886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
    Heskamp S; Hernandez R; Molkenboer-Kuenen JDM; Essler M; Bruchertseifer F; Morgenstern A; Steenbergen EJ; Cai W; Seidl C; McBride WJ; Goldenberg DM; Boerman OC
    J Nucl Med; 2017 Jun; 58(6):926-933. PubMed ID: 28232604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide.
    Lee JD; Yang WI; Lee MG; Ryu YH; Park JH; Shin KH; Kim GE; Suh CO; Seong JS; Han BH; Choi CW; Kim EH; Kim KH; Park KB
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):221-30. PubMed ID: 11926384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ImmunoPET Imaging of Pancreatic Tumors with
    Sobol NB; Korsen JA; Younes A; Edwards KJ; Lewis JS
    Mol Imaging Biol; 2021 Feb; 23(1):84-94. PubMed ID: 32909244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation.
    Luan X; Yuan H; Song Y; Hu H; Wen B; He M; Zhang H; Li Y; Li F; Shu P; Burnett JP; Truchan N; Palmisano M; Pai MP; Zhou S; Gao W; Sun D
    Biomaterials; 2021 Aug; 275():120910. PubMed ID: 34144373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Au@
    Gharibkandi NA; Wawrowicz K; Majkowska-Pilip A; Żelechowska-Matysiak K; Wierzbicki M; Bilewicz A
    EJNMMI Radiopharm Chem; 2023 Oct; 8(1):26. PubMed ID: 37821747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy.
    Garcia-Prada CD; Carmes L; Atis S; Parach A; Bertolet A; Jarlier M; Poty S; Garcia DS; Shin WG; Du Manoir S; Schuemann J; Tillement O; Lux F; Constanzo J; Pouget JP
    J Nucl Med; 2023 Dec; 64(12):1956-1964. PubMed ID: 37857502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.
    Jiménez-Mancilla N; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Isaac-Olivé K; Camacho-López M; Torres-García E
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):663-71. PubMed ID: 25196028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount.
    Konijnenberg MW; Breeman WA; de Blois E; Chan HS; Boerman OC; Laverman P; Kolenc-Peitl P; Melis M; de Jong M
    EJNMMI Res; 2014 Dec; 4(1):47. PubMed ID: 26116111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
    Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
    Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of lipid-soluble complexes in targeted tumor therapy.
    Thakur ML; Coss R; Howell R; Vassileva-Belnikolovska D; Liu J; Rao SP; Spana G; Wachsberger P; Leeper DL
    J Nucl Med; 2003 Aug; 44(8):1293-300. PubMed ID: 12902421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of intratumoural micellar paclitaxel with radiofrequency ablation: efficacy and toxicity in rodents.
    Wu H; Fan ZP; Jiang AN; Di XS; He B; Wang S; Goldberg SN; Ahmed M; Zhang Q; Yang W
    Eur Radiol; 2019 Nov; 29(11):6202-6210. PubMed ID: 30993436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.